Johns Hopkins Adult AIDS CRS

Baltimore, Maryland 21287-8106

0 studies enrolling now · 67 studies all time

What they study most

AIDS-Associated Nephropathy, Candidiasis, Candidiasis, Oral, Cervix, Dysplasia, Cognition Disorders, Cytomegalovirus Infections, Cytomegalovirus Retinitis, HIV, HIV Infection, HIV Infections, HIV Wasting Syndrome, Hepatitis B

Studies at this site

• Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection — Completed
• The Women's HIV SeroIncidence Study (ISIS) — Completed
• A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy — Completed
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes — Completed
• The Treatment of Tuberculosis in HIV-Infected Patients — Completed
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients — Completed
• Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy — Completed
• Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine — Completed
• Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy — Completed
• Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors — Completed
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides — Completed
• A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy — Completed
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis — Completed
• A Study of Disease Progression and Anti-HIV Treatments — Completed
• Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects — Completed
• Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy — Completed
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women — Completed
• A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects — Completed
• A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma — Completed
• A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS — Completed
• A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002 — Completed
• Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals — Completed
• Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma — Completed
• A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure — Completed
• A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 — Completed
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals — Completed
• Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine — Completed
• Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients — Completed
• A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy — Completed
• Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) — Completed
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV — Completed
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation — Completed
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection — Completed
• Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy — Completed
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients — Completed
• Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients — Completed
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS — Completed
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients — Completed
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole — Completed
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs — Completed
• Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults — Completed
• Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers — Completed
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss — Completed
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs — Completed
• Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir — Completed
• Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination — Completed
• Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers — Completed
• A Study of HIV-Disease Development in Aging — Completed
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV — Completed
• Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452 — Completed